| scholarly article | Q13442814 |
| P356 | DOI | 10.1124/JPET.106.101261 |
| P8608 | Fatcat ID | release_wui267mgbbbdbef7qadqga7jhq |
| P698 | PubMed publication ID | 16603671 |
| P5875 | ResearchGate publication ID | 7175630 |
| P2093 | author name string | Glenn A Reinhart | |
| Masaki Nakane | |||
| J Ruth Wu-Wong | |||
| William Noonan | |||
| Sherry J Morgan | |||
| Junli Ma | |||
| Doug Dixon | |||
| Kristin A Koch | |||
| Antoinette L Bolin | |||
| Steve Postl | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vitamin D | Q175621 |
| P304 | page(s) | 90-98 | |
| P577 | publication date | 2006-04-07 | |
| P1433 | published in | Journal of Pharmacology and Experimental Therapeutics | Q1500272 |
| P1476 | title | Role of phosphorus and vitamin D analogs in the pathogenesis of vascular calcification. | |
| P478 | volume | 318 |
| Q46384854 | 25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients |
| Q34683694 | Active vitamin D and accelerated progression of aortic stiffness in hemodialysis patients: a longitudinal observational study. |
| Q37967396 | Can vitamin D slow down the progression of chronic kidney disease? |
| Q37035502 | Cardiovascular risk in chronic kidney disease (CKD): the CKD-mineral bone disorder (CKD-MBD). |
| Q26798487 | Cellular and Molecular Mechanisms of Chronic Kidney Disease with Diabetes Mellitus and Cardiovascular Diseases as Its Comorbidities |
| Q36316104 | Chondro/osteoblastic and cardiovascular gene modulation in human artery smooth muscle cells that calcify in the presence of phosphate and calcitriol or paricalcitol |
| Q38016491 | Chronic kidney disease and vascular remodelling: molecular mechanisms and clinical implications |
| Q46470848 | Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats |
| Q40090279 | Elevated phosphorus modulates vitamin D receptor-mediated gene expression in human vascular smooth muscle cells |
| Q50077724 | Etelcalcetide, A Novel Calcimimetic, Prevents Vascular Calcification in A Rat Model of Renal Insufficiency with Secondary Hyperparathyroidism |
| Q37257887 | Experimental tuberculosis: the role of comparative pathology in the discovery of improved tuberculosis treatment strategies |
| Q28383746 | Increased expression of host iron-binding proteins precedes iron accumulation and calcification of primary lung lesions in experimental tuberculosis in the guinea pig |
| Q38223280 | Is there a need for new phosphate binders to treat phosphate imbalance associated with chronic kidney disease? |
| Q36947028 | Nonclassical aspects of differential vitamin D receptor activation: implications for survival in patients with chronic kidney disease |
| Q37376932 | Potential for vitamin D receptor agonists in the treatment of cardiovascular disease |
| Q26777613 | Pre-treatment considerations in childhood hypertension due to chronic kidney disease |
| Q35247898 | Recent progress in the treatment of vascular calcification |
| Q28271069 | Relation of oral 1alpha-hydroxy vitamin D3 to the progression of aortic arch calcification in hemodialysis patients |
| Q90631576 | Research Models for Studying Vascular Calcification |
| Q37335065 | Role of vitamin D receptor activators on cardiovascular risk |
| Q64079731 | Supplementary nutrients for prevention of vascular calcification in patients with chronic kidney disease |
| Q35059753 | The dualistic role of vitamin D in vascular calcifications |
| Q37762904 | The expanding spectrum of biological actions of vitamin D. |
| Q34412941 | The molecular biology and pathophysiology of vascular calcification |
| Q43658115 | Two novel vitamin D receptor modulators with similar structures exhibit different hypercalcemic effects in 5/6 nephrectomized uremic rats |
| Q56986948 | VDR expression on circulating endothelial progenitor cells in dialysis patients is modulated by 25(OH)D serum levels and calcitriol therapy |
| Q34037021 | Vascular calcification in chronic kidney disease: role of disordered mineral metabolism |
| Q24240439 | Vitamin D compounds for people with chronic kidney disease not requiring dialysis |
| Q38803449 | Vitamin D in patients with chronic kidney disease: a position statement of the Working Group "Trace Elements and Mineral Metabolism" of the Italian Society of Nephrology |
| Q37089710 | Vitamin D receptor activation and survival in chronic kidney disease. |
| Q36796781 | Vitamin D receptor activators can protect against vascular calcification |
| Q33604242 | Vitamin D receptor activators induce an anticalcific paracrine program in macrophages: requirement of osteopontin |
| Q36438261 | Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet |
Search more.